Friday, July 10, 2026

Drug profile · INN

sodium lactate

sodium lactate (SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — sodium lactate
US status
approved
Class
Route
INJECTION
Patents
0
Programs
2
Data quality
0.84

Quick answer

sodium lactate (SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN sodium lactate
Brand SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. APHP220676 Phase 3 · PARItec · Severe hyponatremia and a high risk of rapid SNa overcorrect
  2. 1.6 Phase 2 · Disc Medicine · HIV-1

Frequently asked questions

What is sodium lactate?

sodium lactate (SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for sodium lactate?

SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER is a marketed brand name for sodium lactate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium lactate?

sodium lactate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.